TY - JOUR
AU - Galvan, Bartimée
AU - Ongena, Loïc
AU - Bruyr, Jonathan
AU - Fettweis, Gregory
AU - Lucarelli, Eva
AU - Lavergne, Arnaud
AU - Mariavelle, Emeline
AU - O'Grady, Tina M
AU - Hassoun, Zahrat El Oula
AU - Claes, Margaux
AU - Dubois, Laurence
AU - Lee, Kevin A W
AU - Kruys, Véronique
AU - Gueydan, Cyril
AU - Durand, Jules
AU - Hervouet, Eric
AU - Geyer, Florian
AU - Banito, Ana
AU - Imle, Roland
AU - Mao, Lianghao
AU - Jayavelu, Ashok K
AU - Grünewald, Thomas
AU - Cidre-Aranaz, Florencia
AU - Twizere, Jean-Claude
AU - Dequiedt, Franck
TI - Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma.
JO - Nature Communications
VL - 16
IS - 1
SN - 2041-1723
CY - [London]
PB - Springer Nature
M1 - DKFZ-2025-01397
SP - 6537
PY - 2025
AB - Many cancers are defined by gene fusions that frequently encode oncogenic transcription factors (TFs), such as EWSR1::FLI1 in Ewing sarcoma (EwS). Here, we report that independently to its canonical roles in transcription, EWSR1::FLI1 also functions as an mRNA decay factor, reshaping mRNA stability in EwS. This function participates in EWSR1::FLI1 tumorigenicity and involves interactions of EWSR1::FLI1 with the CCR4-NOT deadenylation complex via its EWSR1-derived low-complexity domain and with the RNA-binding protein HuR/ELAVL1 via its FLI1-derived region. Strikingly, we find that EWSR1::FLI1-mediated mRNA decay antagonizes the normal mRNA protective function of HuR and renders EwS cells highly sensitive to HuR inhibition. Our findings uncover a post-transcriptional function of EWSR1::FLI1 and suggest that targeting mRNA stability mechanisms may offer therapeutic opportunities for EwS.
KW - Sarcoma, Ewing: genetics
KW - Sarcoma, Ewing: metabolism
KW - Sarcoma, Ewing: pathology
KW - Humans
KW - Proto-Oncogene Protein c-fli-1: metabolism
KW - Proto-Oncogene Protein c-fli-1: genetics
KW - RNA Stability: genetics
KW - RNA-Binding Protein EWS: metabolism
KW - RNA-Binding Protein EWS: genetics
KW - Cell Line, Tumor
KW - Animals
KW - Oncogene Proteins, Fusion: metabolism
KW - Oncogene Proteins, Fusion: genetics
KW - Mice
KW - RNA, Messenger: metabolism
KW - RNA, Messenger: genetics
KW - RNA-Binding Proteins: metabolism
KW - RNA-Binding Proteins: genetics
KW - Gene Expression Regulation, Neoplastic
KW - Bone Neoplasms: genetics
KW - Bone Neoplasms: metabolism
KW - Proto-Oncogene Protein c-fli-1 (NLM Chemicals)
KW - EWSR1 protein, human (NLM Chemicals)
KW - RNA-Binding Protein EWS (NLM Chemicals)
KW - FLI1 protein, human (NLM Chemicals)
KW - Oncogene Proteins, Fusion (NLM Chemicals)
KW - RNA, Messenger (NLM Chemicals)
KW - RNA-Binding Proteins (NLM Chemicals)
LB - PUB:(DE-HGF)16
C6 - pmid:40664627
C2 - pmc:PMC12263829
DO - DOI:10.1038/s41467-025-61725-x
UR - https://inrepo02.dkfz.de/record/302857
ER -